Comparative effectiveness of levofloxacin versus third-generation cephalosporins and predictors of treatment outcomes in upper respiratory tract scleroma: a tertiary center experience
Abstract
Upper respiratory tract scleroma is a chronic granulomatous disease that primarily affects the nose but may involve any part of the upper respiratory tract. The mainstay of treatment is prolonged antibiotic therapy. This prospective comparative study included 90 adults with upper respiratory tract scleroma treated at Minia University Hospital, Egypt, between September 2024 and August 2025. Patients were randomly allocated into two equal groups using closed sealed opaque envelopes to receive levofloxacin or third-generation cephalosporins for three months. The mean age was 36.3 ± 10.4 years, and 90% were females. Nasal obstruction (96.7%) and nasal crustation (90%) were the most common manifestations. Rhinolaryngoscleroma was diagnosed in 86.7% of patients, whereas 13.3% had rhinoscleroma. Clinical improvement was significantly higher with levofloxacin than with third-generation cephalosporins (80% vs. 60%, P = 0.038). In the multivariable analysis, treatment type and pharyngeal involvement remained significant predictors of clinical improvement. Levofloxacin treatment was associated with higher odds of improvement (OR = 5.8, P = 0.015). These findings highlight the importance of early diagnosis and appropriate antibiotic selection in the management of upper respiratory tract scleroma.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 90 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.